Balance Sheet
Accounts PayablesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueCurrent LeasesLiabilities and Shareholders EquityLong-Term Deferred TaxNon-Current AssetsNon-Current DebtNon-Current Deferred Tax LiabilityNon-Current Deffered RevenueNotes PayablesOperating LeasesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)Receivables - OtherRetained EarningsShareholder's EquityShort term DebtShort-term InvestmentsTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

ProQR Therapeutics N.V (PRQR) Retained Earnings: 2021-2024

Historic Retained Earnings for ProQR Therapeutics N.V (PRQR) over the last 4 years, with Dec 2024 value amounting to -$456.5 million.

  • ProQR Therapeutics N.V's Retained Earnings fell 5.84% to -$456.5 million in Q4 2024 from the same period last year, while for Dec 2024 it was -$456.5 million, marking a year-over-year decrease of 5.84%. This contributed to the annual value of -$456.5 million for FY2024, which is 5.27% down from last year.
  • Per ProQR Therapeutics N.V's latest filing, its Retained Earnings stood at -$456.5 million for FY2024, which was down 5.27% from -$433.6 million recorded in FY2023.
  • Over the past 5 years, ProQR Therapeutics N.V's Retained Earnings peaked at -$376.0 million during FY2021, and registered a low of -$456.5 million during FY2024.
  • For the 3-year period, ProQR Therapeutics N.V's Retained Earnings averaged around -$425.6 million, with its median value being -$433.6 million (2023).
  • Data for ProQR Therapeutics N.V's Retained Earnings shows a maximum YoY decreased of 12.11% (in 2023) over the last 5 years.
  • Over the past 4 years, ProQR Therapeutics N.V's Retained Earnings (Yearly) stood at -$376.0 million in 2021, then fell by 2.86% to -$386.8 million in 2022, then fell by 12.11% to -$433.6 million in 2023, then decreased by 5.27% to -$456.5 million in 2024.